 LOS ANGELES--BUSINESS WIRE--- IMVT CLASSACTION--Glancy Prongay Murray LLP GPM reminds investors of the upcoming April 20, 2021 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Immunovant, Inc. fka Health Sciences Acquisitions Corporation HSAC, Immunovant, or the Company NASDAQ: IMVT securities between October 2, 2019 and February 1, 2021, inclusive the Class Period. If you suffered a loss on your Immunovant inv 